title: PharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics.
authors.affiliation: Departments of aGenetics bBioengineering, Stanford University Medical Center, Stanford, California cDepartments of Medicine, Indiana University Simon Cancer Center, Indianapolis, Indiana, USA.
authors.forename: Daniella
authors.initials: D
authors.lastname: Lowenberg
authors.forename: Caroline F
authors.initials: CF
authors.lastname: Thorn
authors.forename: Zeruesenay
authors.initials: Z
authors.lastname: Desta
authors.forename: David A
authors.initials: DA
authors.lastname: Flockhart
authors.forename: Russ B
authors.initials: RB
authors.lastname: Altman
authors.forename: Teri E
authors.initials: TE
authors.lastname: Klein
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000493:pharmacokinetics* / Q000494:pharmacology*; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D007069:Ifosfamide / Q000493:pharmacokinetics* / Q000494:pharmacology*; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D010597:Pharmacogenetics; D015398:Signal Transduction
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003577:Cytochrome P-450 Enzyme System; D007069:Ifosfamide